This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Menu
Book
keyboard_arrow_right

DAY THREE

keyboard_arrow_leftSearch & Filter
search

DAY THREE

search
10:00 - 10:055 mins
Chairperson’s Opening Remarks
  • Louisa Maitland - Conference Director, Informa
10:05 - 10:2520 mins
Partnerships and Outsourcing in Clinical Trials (1)
Good partnership relationship with industry and investigator site with an Investigator initiative trial
  • Wolfgang Eglmeier - Head ZKS-UW/H, Witten Herdecke University, Germany
10:05 - 10:2520 mins
Partnerships and Outsourcing in Clinical Trials (2)
Inspection preparation -conduct, organisation and managing a Regulatory Inspection and hear experiences of inspections
  • Karin Tulzer - Global Quality Strategy Lead, Merck KGaA, Austria
10:05 - 10:2520 mins
Operations in Clinical Trials (1)
Conducting clinical trials with COVID-19
  • Amer Alghabban - Senior Director, Clinical Compliance and Training, Freeline Therapeutics, Switzerland
10:05 - 10:2520 mins
Operations in Clinical Trials (2)
Designing cancer trials for the 21st century
  • Sarah Blagden - Associate Professor of Medical Oncology, University of Oxford, UK
10:05 - 10:2520 mins
Technology in Clinical Trials (1)
KEYNOTE: Build a collaborative development framework for novel digital endpoints
  • Kai Langel - Director, Janssen Clinical Innovation (JCI), Janssen, Spain
10:05 - 10:2520 mins
Technology in Clinical Trials (2): Artificial Intelligence
AI-powered recruitment of a digital readiness cohort for Alzheimer’s Disease (AD)
  • Nicklas Linz - Researcher, German Research Centre for Artificial Intelligence (DFKI), Germany
10:25 - 10:4520 mins
Partnerships and Outsourcing in Clinical Trials (1)
Environmental sustainability - Novartis
  • Mairead Lyons - Group Lead, Clinical Project Management, Novartis, Ireland
10:25 - 10:4520 mins
Partnerships and Outsourcing in Clinical Trials (2)
Facilitating optimisation of the performance of clinical trials through enhanced analysis of data from audits and inspections of clinical trials
  • Joanne North - Analytics Lead, Metrics, Reporting and Analytics, BioResearch Quality and Compliance, Johnson & Johnson, UK
10:25 - 10:4520 mins
Operations in Clinical Trials (1)
Impact of patient centered initiatives in clinical trial design and execution
  • Sebastian Stratmann - Senior Manager Clinical Innovation, Merck Healthcare KGaA Biopharma, Germany
10:25 - 10:4520 mins
Operations in Clinical Trials (2)
Regulator’s perspective for complex clinical trials and innovative trial designs
  • Maria Beatrice Panico - Senior Medical Assessor, Clinical Trials Unit, Medicines and Healthcare Products Regulatory Agency, UK
10:25 - 10:4520 mins
Technology in Clinical Trials (1)
An applied framework for evaluating connected sensor technologies
  • Jennifer Goldsack - Executive Director, Digital Medicine Society (DiMe), USA
10:25 - 10:4520 mins
Technology in Clinical Trials (2): Artificial Intelligence
Clinical applications of AI and automatic speech and language analysis with dementia patients to better detect early signs of cognitive decline as well as monitoring disease progression
  • Alexandra Konig - Clinical Researcher, Memory Clinic at Nice University Hospital, University of Côte d'azur, and INRIA Nice, France
10:45 - 11:0520 mins
Partnerships and Outsourcing in Clinical Trials (1)
Spotlight Presentation: Available
    10:45 - 11:0520 mins
    Partnerships and Outsourcing in Clinical Trials (2)
    Spotlight Presentation: Veeva
      10:45 - 11:0520 mins
      Operations in Clinical Trials (1)
      Spotlight Presentation: Sponsor considerations when including mobile research nursing in clinical trials
      • Helen Springford - Chief Executive Officer, Illingworth Research, UK
      10:45 - 11:0520 mins
      Operations in Clinical Trials (2)
      Spotlight Presentation: Optimizing the entire clinical trial financial lifecycle through automation
      • Jim Murphy - CEO, Greenphire, USA
      10:45 - 11:0520 mins
      Technology in Clinical Trials (1)
      Spotlight Presentation: Covance
        10:45 - 11:0520 mins
        Technology in Clinical Trials (2): Artificial Intelligence
        Spotlight Presentation: Available
          11:05 - 11:4540 mins
          Partnerships and Outsourcing in Clinical Trials (1)
          PANEL and Q&A: Ensuring adequate oversight and overcoming the challenges of using external versus internal staff
          • Anna Matranga - Managing Director, AMC Alliances & Consulting, France
          • Karin Tulzer - Global Quality Strategy Lead, Merck KGaA, Austria
          • Stephen Walker - Alliance Management Director , Strategic Enablement, R&D | Global Medicines Development, Clinical Operations, AstraZeneca
          • Virginie Van de Velde - Senior Manager Oversight Data Manager, GSK Vaccines, Belgium
          11:05 - 11:4540 mins
          Partnerships and Outsourcing in Clinical Trials (2)
          PANEL and Q&A: Ensuring adequate oversight and overcoming the challenges of using external versus internal staff
          • Anna Matranga - Managing Director, AMC Alliances & Consulting, France
          • Karin Tulzer - Global Quality Strategy Lead, Merck KGaA, Austria
          • Stephen Walker - Alliance Management Director , Strategic Enablement, R&D | Global Medicines Development, Clinical Operations, AstraZeneca
          • Virginie Van de Velde - Senior Manager Oversight Data Manager, GSK Vaccines, Belgium
          11:05 - 11:4540 mins
          Operations in Clinical Trials (1)
          PANEL and Q&A: KPI’s (Key Performance Indicator) - Quality assessment if undertaking patient engagement correctly?
          • Nicholas Brooke - Founder and Executive Director of The Synergist, PFMD (Patient Focused Medicines Development) and The Synergist
          • Sebastian Stratmann - Senior Manager Clinical Innovation, Merck Healthcare KGaA Biopharma, Germany
          • Paul Robinson - European Lead, Patient Innovation, MSD, UK
          • Marta Garcia - Patient Officer-Clinical Development, Patient In R&D, Servier International, Spain
          • Begonya Nafria Escalera - Patient Engagement in Research Coordinator, Barcelona Children’s Hospital Sant Joan de Déu, Spain
          • Mariangela Lupo - Communication and Patient Advocacy Manager, TEDDY European Network of Excellence for Paediatric Research, Italy
          11:05 - 11:4540 mins
          Operations in Clinical Trials (2)
          PANEL and Q&A: KPI’s (Key Performance Indicator) - Quality assessment if undertaking patient engagement correctly?
          • Nicholas Brooke - Founder and Executive Director of The Synergist, PFMD (Patient Focused Medicines Development) and The Synergist
          • Sebastian Stratmann - Senior Manager Clinical Innovation, Merck Healthcare KGaA Biopharma, Germany
          • Paul Robinson - European Lead, Patient Innovation, MSD, UK
          • Marta Garcia - Patient Officer-Clinical Development, Patient In R&D, Servier International, Spain
          • Begonya Nafria Escalera - Patient Engagement in Research Coordinator, Barcelona Children’s Hospital Sant Joan de Déu, Spain
          • Mariangela Lupo - Communication and Patient Advocacy Manager, TEDDY European Network of Excellence for Paediatric Research, Italy
          11:05 - 11:4540 mins
          Technology in Clinical Trials (1)
          LIVE PANEL and Q&A: What are the main challenges of AI and what advancements have been made?
          • Deepak Bandyopadhyay - Associate Director of Quality Analytics,, Janssen, USA
          • Corrette Ploem - Associated Professor, University Medical Centre (UMC) Amsterdam, Netherlands
          • Michel Arnoult - Chairman, Arnoult.org, France
          • Alexandra Konig - Clinical Researcher, Memory Clinic at Nice University Hospital, University of Côte d'azur, and INRIA Nice, France
          11:05 - 11:4540 mins
          Technology in Clinical Trials (2): Artificial Intelligence
          LIVE PANEL and Q&A: What are the main challenges of AI and what advancements have been made?
          • Deepak Bandyopadhyay - Associate Director of Quality Analytics,, Janssen, USA
          • Corrette Ploem - Associated Professor, University Medical Centre (UMC) Amsterdam, Netherlands
          • Michel Arnoult - Chairman, Arnoult.org, France
          • Alexandra Konig - Clinical Researcher, Memory Clinic at Nice University Hospital, University of Côte d'azur, and INRIA Nice, France
          11:45 - 12:4560 mins
          Networking
          LIVE Networking Forum
            11:45 - 12:1530 mins
            Tech Tour
            Tech Tour
              12:45 - 12:5510 mins
              AFTERNOON PLENARY
              Chairperson’s Opening Remarks
              • Bruce Hellman - CEO, Umotif
              12:55 - 13:1520 mins
              AFTERNOON PLENARY
              Accelerating the drug development paradigm during and post pandemic
              • Kenneth Getz - Deputy Director and Professor, Tufts Center for the Study of Drug Development Tufts University, USA
              13:15 - 13:3520 mins
              AFTERNOON PLENARY
              BREXIT – What impact will this have on clinical trials in the UK?
              • Sheuli Porkess - Executive Director Research Medical & Innovation, Association of the British Pharmaceutical Industry (ABPI), UK
              13:35 - 13:5520 mins
              AFTERNOON PLENARY
              Future of medicine- Cell and gene therapy, precision medicine and personalised medicine
              • Anita Nelsen - Senior Vice President, Translational Medicine, Parexel International, UK
              13:55 - 14:3540 mins
              AFTERNOON PLENARY
              LIVE PANEL with Q&A: The future of clinical trials
              • Julianne Hull - CEO, WenStar Enterprizes
              • Kenneth Getz - Deputy Director and Professor, Tufts Center for the Study of Drug Development Tufts University, USA
              • Sheuli Porkess - Executive Director Research Medical & Innovation, Association of the British Pharmaceutical Industry (ABPI), UK
              • Richard Stephens - Chair of the National Cancer Research Institute's Consumer Forum, National Cancer Research Institute’s Consumer Forum (NCRI)
              • Kai Langel - Director, Janssen Clinical Innovation (JCI), Janssen, Spain
              • Matthew Bonam - Head of R&D Digital, AstraZeneca R&D
              • Anita Nelsen - Senior Vice President, Translational Medicine, Parexel International, UK
              14:35 - 15:3560 mins
              Networking
              LIVE Networking Forum
                15:35 - 15:4510 mins
                AFTERNOON PLENARY
                Christine Pierre Lifetime Achievement Award in Association with mdgroup
                  15:45 - 15:5510 mins
                  AFTERNOON PLENARY
                  Clinical Trials Europe Virtual Exhibition Stand Award Sponsored by PharmaTargeting
                    15:55 - 16:3540 mins
                    AFTERNOON PLENARY
                    Inspirational Speaker: Medical Aspects of Space travel
                    • André Kuipers - Astronaut, Physician, Ambassador of the Earth, The Netherlands
                    16:35 - 17:3560 mins
                    LIVE Networking Reception
                      17:35 - 17:405 mins
                      End of Conference
                        DAY TWO

                        Get the latest news.
                        As it happens

                        Sign up to get the latest on the agenda and speakers.
                        Filter
                        Streams
                        Formats
                        Topics
                        Choose Day